7.2 End of life care
Main inclusion criteria
Studies involving all issues related to palliative care and end of life care including:
- assessment of patient, service user and carer needs
- provision and evaluation of palliative and end of life care services
- quality of life for patients and carers
- evaluation of interventions for health and social care professionals
- social, economic and policy issues
- pain management for terminally ill people
- bereavement
Official terminology
|
Full name of code |
Short name | Unique ID |
| 7.2 End of life care | 7.2 Palliative |
HRCS_RA_7_2 |
Related external links
Common Scientific Outline (CSO) – 6.6 End of Life Care
Main inclusion criteria
Studies of patients and service user care needs including:
- quality of life, management of acute and chronic symptoms, management of side effects, rehabilitation, long term morbidity and reproductive issues
- psychological impact of illness
- social and economic consequences of ill health
- behaviour affecting disease management including secondary prevention, compliance to treatment and attitudes and beliefs relating to seeking treatment
- assessment of social care and health services needs
- educational or communication interventions to promote self-care or improve health care by carers
- impact on carers
Advice on research activities
Includes research into or promoting management of diseases or conditions by service users such as user education and communication research.
Excludes services users experiences of health services which should be coded as 8.1 Organisation and delivery of services.
Do not use to code for the quality of life component of a therapeutic trial – code for the therapeutic investigation only.
Official terminology
|
Full name of code |
Short name | Unique ID |
| 7.1 Individual care needs | 7.1 Individual needs |
HRCS_RA_7_1 |
Related external links
Common Scientific Outline (CSO) – 6.1 Patient Care and Survivorship Issues
Common Scientific Outline (CSO) – 6.3 Population-based Behaviour Factors
Advice on research activities
Therapeutic clinical trials in the 6 Treatment Evaluation code group will often include an assessment of quality of life. However the main aim of these studies is usually to evaluate the effect or suitability of the intervention.
Unless one of the primary aims of a trial is investigating quality of life, just code for the therapy under investigation and not also to 7.1 Individual care needs for the quality of life component.
The 7.1 individual care needs code should only be used for research where assessments of quality of life are the main focus of the study.
Main inclusion criteria
Testing and evaluation of therapeutic interventions in clinical, community or applied settings.
Advice on research activities
Research coded within this code group should involve patients in the testing and evaluation of therapies or be in a clinical or applied setting.
Note not all trial evaluation is in 6 Treatment Evaluation, only if the trial relates to treatment evaluation.
Clinical trials in this category will often involve an economic evaluation and quality of life component. Unless one of the primary aims of these trials is assessing quality of life or health economics, just code for the therapy under investigation.
Official terminology
|
Full name of code |
Short name | Unique ID |
| 6 Evaluation of treatments and therapeutic interventions | 6 Treatment evaluation |
HRCS_RAG_6 |
Related external links
Common Scientific Outline (CSO) – 5 Treatment
Summary of Treatment Evaluation sub-codes
6.1 Pharmaceuticals
Clinical application and evaluation of pharmaceutical small molecules, therapeutic vaccines, antibodies and hormones in humans including:
- small scale settings and pilot studies
- phase I, II, III and IV trials
- assessing sensitivity, efficacy, specificity, relapse, survival, therapeutic value, pharmacokinetics, reproducibility and safety
- studies monitoring response, outcome, drug resistance and side effects
6.2 Cellular and gene therapies
Clinical application and evaluation of cellular, tissue and gene therapies in humans including:
- small scale and pilot studies
- phase I, II, III and IV trials
- gene therapy, stem cell therapy, in vitro fertilisation, tissue engineering
- Fecal microbiota transplantation (FMT)
- evaluation of applied delivery systems
6.3 Medical devices
Application and evaluation of medical devices in humans in a clinical, community or applied setting including:
- implantable devices, mobility aids, dressings, medical equipment and prostheses
- validation of design and post market surveillance
6.4 Surgery
Clinical and applied application and evaluation of surgical, obstetric and dental interventions in humans including:
- small scale and pilot studies
- phase I, II, III and IV trials
- procedures including organ and bone marrow transplantation, tissue grafts and transfusions
- monitoring outcomes, side effects and rejection
6.5 Radiotherapy and other non-invasive therapies
Clinical application and evaluation of interventions in humans including:
- small scale and pilot studies
- phase I, II, III and IV trials
- radiotherapy, radioimmunotherapy and radiosensitisers, microwaves, ultrasound, laser and phototherapy
- monitoring side effects
6.6 Psychological and behavioural
Application and evaluation of psychological and behavioural interventions in humans in clinical, community and applied settings including:
- phase I, II, III and IV trials
- cognitive behavioural therapy, electro-convulsive therapy, counselling, therapy and social interventions
6.7 Physical
Testing and evaluation of physical interventions in humans in a clinical, community or applied setting including:
- physical therapies, physiotherapy, occupational therapy, speech therapy, dietetics, osteopathy and exercise
6.8 Complementary
All aspects of testing, evaluation and provision of complementary approaches to conventional medicine in humans in a clinical, community or applied setting including:
- hypnotherapy, massage, acupuncture and homeopathy
- issues relating to health and social services and health care delivery
- attitudes and beliefs of patients and health care professionals
6.9 Resources and infrastructure (treatment evaluation)
- provision and distribution of resources related to clinical and applied therapeutic interventions
- infrastructure support for clinical and applied research networks and trials, consortia and centres